Dataset from A Phase III, Randomized, Double-Blind Placebo-Controlled, Multicenter Study To Evaluate the Efficacy and Safety of Baloxavir Marboxil in Combination With Standard-of-Care Neuraminidase Inhibitor in Hospitalized Participants With Severe Influenza
收藏NIAID Data Ecosystem2026-05-10 收录
下载链接：
https://doi.org/10.25934/PR00008869
下载链接
链接失效反馈官方服务：
资源简介：
This study will evaluate the efficacy, safety, and pharmacokinetics of baloxavir marboxil in
combination with a standard-of-care (SOC) neuraminidase inhibitor (NAI) (i.e., oseltamivir,
zanamivir, or peramivir) compared with a matching placebo in combination with a SOC NAI in
hospitalized patients with influenza.
创建时间：
2026-01-05
